W.-Y. Lo

Dr. W.-Y. Lo is a cancer researcher at the German Cancer Research Center (DKFZ), specializing in breast cancer pharmacogenomics and genetic epidemiology. Their recent work focuses on understanding genetic factors influencing aromatase inhibitor treatment outcomes in breast cancer patients.

Research interests include genetic epidemiology of breast cancer, pharmacogenomics of endocrine therapies, and germline genetic variants related to treatment response. Dr. Lo employs candidate gene approaches and large-scale genomic analyses to investigate associations between genetic variants and clinical outcomes in hormone receptor-positive breast cancer.

Dr. Lo's recent publication demonstrates expertise in analyzing genetic factors affecting aromatase inhibitor efficacy, with implications for personalized treatment approaches in breast cancer management. Their work bridges genetic research and clinical oncology, contributing to understanding why certain patients respond differently to standard endocrine therapies.

As part of the DKFZ research community, Dr. Lo collaborates with epidemiologists, geneticists, and clinical oncologists on studies examining the genetic basis of cancer susceptibility and treatment outcomes.